Company Aarti Drugs Limited

AARTIDRUGS

INE767A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:24:32 12/02/2026 pm IST			5-day change	1st Jan Change
374.25 ^INR	-0.31%		+1.09%	-9.13%

04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026
03/02	Aarti Drugs dividend 2 rupees per share	RE

Business description: Aarti Drugs Limited

Aarti Drugs Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals includes benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

Number of employees: 1,284

Sales by Activity: Aarti Drugs Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Pharmaceuticals	2.15TCr	2.49TCr	2.72TCr	2.53TCr	2.39TCr

See all business segments

Geographical breakdown of sales: Aarti Drugs Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
India	1.38TCr	1.57TCr	1.64TCr	1.67TCr	1.52TCr
Out of India	773.23Cr	922.33Cr	1.07TCr	862.88Cr	865.33Cr

See all geographic segments

Executive Committee: Aarti Drugs Limited

Manager	Title	Age	Since
Prakash Moreshwar Patil CEO	Chief Executive Officer	78	01/06/2007
Adhish P. Patil DFI	Director of Finance/CFO	43	06/07/2012
Rushikesh Deole CMP	Compliance Officer	-	23/04/2019
Rashesh Chandrakant Gogri PRN	Corporate Officer/Principal	51	26/09/2014
Harshit Manilal Savla CEO	Chief Executive Officer	63	02/01/1987

See AARTI DRUGS LIMITED governance

Composition of the Board of Directors: Aarti Drugs Limited

Director	Title	Age	Since
Prakash Moreshwar Patil CHM	Chairman	78	01/04/2014
Harit Pragji Shah BRD	Director/Board Member	62	01/06/2007
Chandrakant V. Gogri CHM	Chairman	79	-
Uday Moreshwar Patil BRD	Director/Board Member	62	24/12/2009
Harshit Manilal Savla BRD	Director/Board Member	63	02/01/1987
Rashesh Chandrakant Gogri BRD	Director/Board Member	51	01/10/2012
Narendra Jagannath Salvi BRD	Director/Board Member	61	25/08/2020
Ankit Vikram Paleja BRD	Director/Board Member	42	13/10/2021
Bhaskar Narayan Thorat BRD	Director/Board Member	-	09/05/2022
Neha Rajen Gada BRD	Director/Board Member	49	09/05/2022

Composition of the Board of Directors

Shareholders: Aarti Drugs Limited

Name	Equities	%	Valuation
Prakash Moreshwar Patil 9.624 %	87,83,869	9.624 %	36 M ₹
DSP Asset Managers Pvt. Ltd. 8.009 %	73,10,185	8.009 %	30 M ₹
Harshit Manilal Savla 4.737 %	43,23,269	4.737 %	18 M ₹
Rashesh Chandrakant Gogri 4.644 %	42,38,874	4.644 %	18 M ₹
Priti Prakash Patil 4.4 %	40,16,315	4.4 %	17 M ₹

List of AARTI DRUGS LIMITED shareholders

Company details: Aarti Drugs Limited

Aarti Drugs Ltd.

Mahendra Industrial Estate

400022, Mumbai

+91 22 2401 9025

http://www.aartidrugs.co.in

Group companies: Aarti Drugs Limited

Name	Category and Sector
Pinnacle Life Science Pvt Ltd. Pinnacle Life Science Pvt Ltd. Manufactures and distributes tablets, capsules, syrups, suspension, ointments and creams
Pinnacle Life Science Pvt Ltd. Pinnacle Life Science Pvt Ltd. Manufactures and distributes tablets, capsules, syrups, suspension, ointments and creams

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
AARTI DRUGS LIMITED	-0.31%	+1.09%	-4.95%	-2.30%	38Cr
ELI LILLY AND COMPANY	+2.20%	+1.35%	+18.52%	+195.28%	91TCr
JOHNSON & JOHNSON	+1.56%	+2.74%	+57.35%	+50.11%	58TCr
ABBVIE INC.	+2.18%	+2.71%	+16.56%	+46.33%	39TCr
ROCHE HOLDING AG	+0.81%	+0.28%	+23.31%	+28.83%	37TCr
NOVARTIS AG	+0.57%	+3.79%	+26.58%	+53.94%	30TCr
ASTRAZENECA PLC	+0.73%	+6.77%	+26.47%	+30.68%	31TCr
MERCK & CO., INC.	+1.85%	+1.31%	+41.61%	+10.74%	30TCr
NOVO NORDISK A/S	-0.05%	+9.23%	-47.66%	-38.32%	22TCr
AMGEN INC.	-0.18%	-0.40%	+24.15%	+50.34%	20TCr
Average	+0.90%	+0.91%	+18.19%	+42.56%	35.78TCr
Weighted average by Cap.	+1.33%	-0.56%	+24.70%	+74.40%